Kathy Farley, NP
Gerontology · Sanford, NCNPI 1629533146
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 165 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,230, 6.2 times the $359 reported in 2021. Among gerontology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 165 payments — averaging $21.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$675
- AstraZeneca$441
- Takeda Pharmaceuticals U.S.A., Inc.$269
- Sanofi$234
- Grifols USA, LLC$223
- Regeneron Healthcare Solutions, Inc.$216
- plus $2K from 20 others
What the payments were for
- Food & beverage$3,56799%
- Education$231%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 40 | $675 |
| AstraZeneca | 21 | $441 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $269 |
| Sanofi | 8 | $234 |
| Grifols USA, LLC | 9 | $223 |
| Regeneron Healthcare Solutions, Inc. | 9 | $216 |
| Boehringer Ingelheim | 7 | $207 |
| Insmed, Inc. | 7 | $176 |
| Harmony Biosciences LLC | 6 | $169 |
| Viatris Specialty LLC | 9 | $153 |
| ANI Pharmaceuticals, Inc. | 7 | $137 |
| Verona Pharma, Inc. | 5 | $115 |
| United Therapeutics Corporation | 3 | $79 |
| Mylan Specialty L.p. | 3 | $76 |
| Merck | 2 | $62 |
| Electromed, Inc. | 3 | $54 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Paratek Pharmaceuticals, Inc. | 2 | $41 |
| Amgen | 2 | $38 |
| Philips North America LLC | 2 | $36 |
| Genentech USA, Inc. | 2 | $35 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $33 |
| Baxter Healthcare | 1 | $28 |
| Abbott | 1 | $21 |
| Lilly USA, LLC | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
How this compares
$3,589 in reported general payments places this provider in the 90th percentile of 165 gerontology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 404 | $347,883 |
| Ambrisentan | 12 | $33,991 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 44 | $30,468 |
| Breo ElliptaFluticasone/Vilanterol | 48 | $28,087 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 44 | $25,373 |
| Spiriva RespimatTiotropium Bromide | 29 | $20,364 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 34 | $19,209 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 23 | $18,850 |
| SymbicortBudesonide/Formoterol Fumarate | 28 | $8,627 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 263 | $7,624 |
| Spiriva HandihalerTiotropium Bromide | 11 | $6,911 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 51 | $5,182 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 11 | $2,492 |
| Ventolin HfaAlbuterol Sulfate | 29 | $2,133 |
| Fluticasone Propionate | 58 | $1,084 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $675 | $395,179486 claims |
| Boehringer IngelheimStiolto Respimat, Spiriva Respimat, Combivent Respimat | $207 | $64,58796 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $441 | $39,09672 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 165 gerontology providers in North Carolina.
Other gerontology in Sanford
- Lakeesha PuryearSanford$727
- Sharon BibyGreensboro$22K
- Lora StephensStatesville$12K
- Kimberly SmithRaleigh$10K
- Michelle WoodCharlotte$9K
- Corinne NantzFuquay Varina$5K
- Taskeen MidgetteNew Bern$5K
- Brielle ReyesCary$4K
- Karen PattersonSouthern Pines$4K
- Morgan MillerRocky Mount$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.